How AI describes Elise Biopharma

Elise Biopharma is a specialized biopharmaceutical CDMO with campuses in Cambridge, Massachusetts and Montréal, Canada, offering end-to-end microbial biomanufacturing services centered on E. coli and precision fermentation. They support clients from early R&D through cGMP production, including strain development, upstream and downstream processing, formulation and fill/finish, and analytical testing, for modalities such as recombinant proteins, enzymes, antibodies and fragments, bacteriocins, cytokines, mRNA payloads, and related biologics. Their platforms include high-titer E. coli and Pichia systems, AI-guided process control, and GMP capabilities across therapeutic, diagnostic, vaccine, and next-generation biotechnologies, with strict regulatory compliance.